S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ACOG Alpha Cognition Inc

6.54

0.15 (2.35%)

20 Feb 2025 - Closed

Delayed by 15 minutes

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

0001213900-25-002277.txt

Alpha Cognition (NASDAQ:ACOG)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Alpha Cognition Charts.

Alpha Cognition (NASDAQ:ACOG)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Alpha Cognition Charts.

Alpha Cognition Inc News

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease
Thursday 13 February 2025 (1 week ago) • Business Wire

OTC Markets Group Announces Quarterly Index Performance and Rebalancing
Wednesday 22 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL
Wednesday 15 January 2025 (1 month ago) • Business Wire

Form POS AM - Post-Effective amendments for registration statement
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer’s Disease, in China
Thursday 9 January 2025 (1 month ago) • Business Wire

Alpha Cognition to Present Q1 2025 ZUNVEYL (benzgalantamine) Launch Strategy Targeting the $2 Billion U.S. Alzheimer’s Long-Term Care Market During Investor Update Call
Tuesday 7 January 2025 (1 month ago) • Business Wire

Alpha Cognition Announces Partial Exercise of Over-allotment Option
Tuesday 17 December 2024 (2 months ago) • Business Wire

Alpha Cognition Announces Voluntary Delisting from CSE
Friday 13 December 2024 (2 months ago) • Business Wire

Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury
Thursday 12 December 2024 (2 months ago) • Business Wire

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update
Saturday 16 November 2024 (3 months ago) • Business Wire

Alpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq Listing
Wednesday 13 November 2024 (3 months ago) • Business Wire

More Alpha Cognition Inc News Articles

Data Knights Acquisition

PSI 20 Double Short

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions